Double hit on melanoma unlocks barrier to immunotherapy

Researchers at EPFL and UNIL have discovered a dangerous liaison between immune cells that limits the efficacy of immunotherapy in melanoma. But they also found a way to disrupt it.

Dons

Aidez
la Fondation ISREC
dans sa mission de
soutien à la recherche sur le cancer

Nous aider

Fondation ISREC
Rue du Bugnon 25A
CH-1005 Lausanne / Suisse
CCP 10-3224-9
Tél. : +41 21 653 07 16

Formulaire de contact